PIXITMEDIA
Leading software-defined storage and data management solution provider, pixitmedia, a Kalray company, and Lenovo, the Fortune Global 500 technology powerhouse, are now offering a cost-effective and ultra-scalable cloud-enabled hyper-converged solution to the Media and Entertainment industry. Hyper-converged, or HCI, unites pixitmedia’s award-winning software, pixstor™ with ngenea®, with Lenovo’s smart solutions into a single appliance, with guaranteed performance suitable for a multitude of Media and Entertainment workflows.
Historically, studios have depended on storage products supplied by major data appliance vendors. Most vendors are either yet to evolve cloud-based solutions or offer very limited cloud capabilities. This is restrictive and limits the flexibility of media creation companies as their businesses grow and content delivery models change. Having a hyper-converged infrastructure gives studios the freedom to choose where to grow their capabilities, whether it be on-premise or in the cloud. Those working remotely should have the same experience as those who choose to work on-premises and vice versa. For companies operating virtual workstations, this is a vital part of the workflow, and it is where dynamic data management can bring huge benefits. A hyper-converged approach allows creative media businesses to stay agile and keep infrastructure costs low by virtualising key elements of conventional “hardware-defined” systems.
“pixitmedia and Lenovo liberate Media and Entertainment businesses from being locked into restrictive data environments. Studios that are able to quickly adjust infrastructure, keep up with productivity and meet content demands, are able to stay competitive. A hyper-converged approach enables creative media businesses of any size to stay agile and keep infrastructure costs lower" explains Ben Leaver, EVP of Business Development, pixitmedia.
“The Media and Entertainment sector is a complex and exciting industry and Lenovo is committed to working with partners to create solutions which offer customers value. In collaboration with pixitmedia we’ve developed a solution which makes it easy for companies in this sector to deploy a hyper-converged environment.” says Ian Jeffs, UK and Ireland General Manager, Lenovo Infrastructure Solutions Group.
The collaboration between pixitmedia and Lenovo has resulted in a Hyperconverged solution that guarantees customers complete control of their data. All users can see and access the same data securely, enabling rock-solid collaboration between multiple creative sites. The solution enables businesses a simplistic transition to cloud and hybrid ways of working with no disruption to existing workflows and no compromise on security, whilst delivering guaranteed ultra-fast performance. For ultimate flexibility, the pixitmedia HCI solution works with any cloud provider over a multitude of production workflows, giving the customer the flexibility to scale up or down according to projects. pixitmedia, a global leader in cloud-workflow solutions for Media and Entertainment, has already deployed multiple hybrid solutions to over 20 global media production and distribution companies.
The solution works seamlessly across multiple operating systems and leverages cloud providers’ networks for ultra-high-speed data transfers, businesses can easily expand on-premises pipelines into the cloud with a software-defined solution such as pixstor™, while still enjoying the guaranteed sustained collaboration, performance, scalability and intelligent management tools of an on-premises deployment. Supported by ngenea®, an intelligent data transport mechanism, business experiences can be tightly integrated on-premises, and cloud infrastructure integrated under a single namespace.
By adopting integrated cloud solutions such as ngenea® and pixstor™, media creation businesses will have everything that they need, from on-premises to remote working and everything in between. pixitmedia also offers an upgrade path for the HCI solution to scale-out NAS as your business grows to give customers that added flexibility for the future.
Working together with Lenovo is about driving business forward and empowering customer workflows. Hyper-converged infrastructure offers scalability and agility, optimised performance and collaboration and the option to reduce costs. In simple terms, it gives media enterprises more choices, more collaborative efficiencies and more freedom than ever before.
For more information on pixitmedia and Lenovo HCI solutions please visit: pixitmedia.com/lenovo/
ABOUT LENOVO
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$70 billion revenue global technology powerhouse, ranked #171 in the Fortune Global 500, employing 75,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s leading PC player by expanding into new growth areas of infrastructure, mobile, solutions and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and sustainable digital society for everyone, everywhere.
ABOUT PIXITMEDIA
pixitmedia is a Kalray company (Euronext Growth Paris: ALKAL), a leading provider of hardware and software technologies and solutions for high-performance, data-centric computing markets, from cloud to edge. pixitmedia and Kalray share a common vision and a complementary value proposition in both software and hardware to address today’s and tomorrow’s data-intensive world with solutions for a more intelligent, effective, energy-wise and user-friendly data-driven world.
pixitmedia’s award-winning purpose-built, software-defined storage and data solutions simplify the flow of data to connect an increasingly complex world. We devise optimized solutions that give customers both choice and freedom, our restless innovation constantly pushes boundaries and the unrivalled care and knowledge of our team ensure optimum performance and value. Customer success is at the heart of our business, we have technical specialists and a unique, dedicated lab facility to guarantee the effectiveness of our solutions. For more information, please visit https://pixitmedia.com or contact us: marketing@pixitmedia.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221117005654/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release
Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe7.1.2026 08:30:00 CET | Press release
Exclusive agreement covers 13 Central and Eastern European markets Collaboration will help expand access to VANFLYTA for patients with newly diagnosed FLT3-ITD positive AML Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnose
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom